Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
US5994330A · kind A · utility
69Cited by
8References
22Claims
0Family size
Inventor
Key dates
| Filing date | Nov 9, 1998 |
| Grant date | Nov 30, 1999 |
| Priority date | — |
| Expiry date | Nov 9, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treatment of acne through topical administration is an aspect of the present invention. Specifically, muscarinic agents may be applied in any therapeutically acceptable carrier including gels, creams, lotions, and sprays. Therapeutic effects observed with the present invention include decrease in redness, swelling, and inflammation. Treatment of other inflammatory conditions is also disclosed. Treatment of suitable conditions in accordance with the present invention results in significant improvements in healing of those conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.